Cargando…
Effective treatment of canine chronic cutaneous lupus erythematosus variants with oclacitinib: Seven cases
BACKGROUND: The treatment of canine chronic cutaneous lupus erythematosus (CCLE) variants generally requires immunosuppression, which often results in potentially severe adverse effects. Janus kinase inhibitors, like oclacitinib, might be a valuable treatment option due to their rapid inhibition of...
Autores principales: | Harvey, Richard G., Olivrī, Alla, Lima, Tatiana, Olivry, Thierry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092348/ https://www.ncbi.nlm.nih.gov/pubmed/36229964 http://dx.doi.org/10.1111/vde.13128 |
Ejemplares similares
-
011 Systemic hyperinflammation as a driver of maculopapular drug exanthema in severely ill COVID-19 patients?
por: Mitamura, Y., et al.
Publicado: (2021) -
028 Use of systemic immunosuppressive treatment is not related to COVID-19 infection in a retrospective review of patients in Massachusetts
por: Murphy, W., et al.
Publicado: (2021) -
032 A multicomponent skin-targeted COVID-19 vaccine elicits robust humoral and cellular immune responses
por: Balmert, S.C., et al.
Publicado: (2021) -
Increased expression of the urokinase plasminogen activator system by Helicobacter pylori in gastric epithelial cells
por: Kenny, Susan, et al.
Publicado: (2008) -
EP(2) and EP(4) receptors on muscularis resident macrophages mediate LPS-induced intestinal dysmotility via iNOS upregulation through cAMP/ERK signals
por: Tajima, Tsuyoshi, et al.
Publicado: (2012)